WASHINGTONPOST (Ariana Eunjung Cha) - She lived with headaches and brain fog for years. Then she tried magic mushrooms.
Elizabeth Richwine is at the frontier of a psychedelic boom that could transform medicine — and create a massive new industry.
NEWSNATIONNOW (Rob Taub) - Psilocybin may help prevent painful chemotherapy side effect, study finds
A new study suggests psilocybin could protect nerves from chemotherapy damage, potentially helping patients avoid a debilitating side effect.
AMERICANALMANAC (Jonah Adams) - Americans are abandoning conventional medicine for toad venom and mushrooms — and a $193 billion industry is cashing in
A growing number of Americans are turning to psychedelics, spiritual ceremonies, and other alternative treatments after losing faith in conventional medicine, a trend now backed by a nearly $200 billion global industry. Sly Young chose toad venom over antidepressants. She made that decision deliberately, fully aware of how it sounded. During the pandemic, her conventional […] The post Americans are abandoning conventional medicine for toad venom and mushrooms — and a $193 billion industry is cashing in appeared first on American Almanac .
A growing number of Americans are turning to psychedelics, spiritual ceremonies, and other alternative treatments after losing faith in conventional medicine, a trend now backed by a nearly $200 billion global industry. Sly Young chose toad venom over antidepressants. She made that decision deliberately, fully aware of how it sounded. During the pandemic, her conventional treatments for neurodivergence and chronic PTSD stopped working as well as they once had. So she went looking for something else, and found shamans, sacred ceremonies, and microdosed mushrooms supplied by a friend. Young's story, profiled by USA Today , is not an outlier. It sits inside a documented national shift away from mainstream Western medicine and toward a…Open
YOUTUBE (Fox Business) - UNPRECEDENTED: VA psychedelic trials take off #shorts
Veterans Affairs Secretary Doug Collins discusses a psilocybin depression trial for veterans on ‘Mornings with Maria.’ #foxbusiness #shorts
YOUTUBE (Fox Business) - VA GAME CHANGER: Trump’s VA makes MAJOR breakthrough
Veterans Affairs Secretary Doug Collins discusses GLP-1 drugs for alcohol use disorder, $10.44 billion in drug price reductions, a psilocybin depression trial and AI-powered health care technology on ‘Mornings with Maria.’ #foxbusiness #morningswithmaria 0:09 — VA tests GLP-1 drugs to curb alcohol cravings in veterans 1:43 — Collins on helping veterans stay healthy and active 2:28 — VA monitoring deployed troops’ health and transition home 3:18 — VA secures record $10 billion in prescription drug savings 4:46 — Psychedelic trials, digital records and AI reshape veteran care
NYTIMES (Noah Daly and Andrew Jacobs) - Americans Encounter Risks at Psychedelic Clinics Abroad
Participants, often in vulnerable states, have little recourse if mistreated or injured.
NPR (Will Stone) - Real-world study of Oregon's nonmedical psilocybin program shows promise
Oregon was the first state to establish a legalized and regulated psilocybin industry. Since then, thousands have tried magic mushrooms. Here is the latest data from the state's real life experiment.
HUFFPOST - U.S. Olympic Icon Arrested On Drug Charges
The athlete was arrested on a charge of possessing psilocybin mushrooms.
NEWSNATIONNOW (Zach Kaplan) - Alzheimer's patient showed improved cognition after psilocybin: Report
The woman, who typically speaks in single syllables, showed measurable improvements.
YOUTUBE (The Hill) - Watch Now! Rethinking Psychedelic Treatment for America's Mental Health Crisis
Psychiatry is at an inflection point. And the stakes are high. Mental illness costs the U.S. economy more than $280 billion annually, drives veteran suicide rates, and places mounting strain on everything from emergency rooms to the workforce. Yet many of today’s medicines have not advanced in decades despite the rising prevalence and unmet need. For the one in five Americans living with a mental health disorder and veterans who face disproportionally high suicide rates and do not respond to conventional treatments, the gap between what medicine promises and what it delivers has never been more consequential. But change is underway. A new wave of rigorous clinical science is unlocking the therapeutic potential of psychedelic medicines…